[Modification of the action in vitro of bradykinin by blocking of adrenergic receptors].
D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology*; D004386:Duodenum / Q000187:drug effects*; D004878:Ergotamine / Q000494:pharmacology*; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects*; D066298:In Vitro Techniques; D009570:Nitriles / Q000494:pharmacology*; D011299:Prenylamine / Q000494:pharmacology*; D051381:Rats; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D009570:Nitriles; D013565:Sympatholytics; D014665:Vasodilator Agents; D014700:Verapamil; D011299:Prenylamine; D000109:Acetylcholine; D004878:Ergotamine; D001920:Bradykinin
Modificazione dell'azione in vitro della bradichinina per blocco dei recettori adrenergici.